Development & Commercialization Partnerships

MannKind Corporation is seeking attractive opportunities to develop mutually beneficial partnerships with other companies related to its core Technosphere® formulation technology as its work on developing additional applications for its proprietary technology drug delivery platform. The company is also interested in exploring potential collaborations to assist us in the development and commercialization of its lead product, Technosphere® Insulin System, in the U.S. and other parts of the world.

MannKind believes there are significant opportunities both for its lead product and for its proprietary technologies to develop and apply its innovative, protein peptide molecular delivery system to a variety of potential products and uses. The ultimate aim is to bring important new benefits to patients in areas of significant unmet medical need.

For more information, please contact:

James Weissman
Vice President, Business Development
(201) 983-5113